These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 8611456)
1. Evidence for an active fibrinolytic system in normal human bone marrow. McWilliam NA; Robbie LA; Barelle CJ; Adey G; Prasad S; Bennett B; Booth NA Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456 [TBL] [Abstract][Full Text] [Related]
2. The fibrinolytic system in human ascites. Buø L; Karlsrud TS; Dyrhaug G; Bell H; Engström L; Johansen HT; Aasen AO Scand J Gastroenterol; 1995 Nov; 30(11):1101-7. PubMed ID: 8578171 [TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow. McWilliam N; Robbie L; Booth N; Bennett B Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer. Casslén B; Bossmar T; Lecander I; Astedt B Eur J Cancer; 1994; 30A(9):1302-9. PubMed ID: 7999418 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis. Gissler HM; Frank R; Kramer MD Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853 [TBL] [Abstract][Full Text] [Related]
6. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Kummer JA; Abbink JJ; de Boer JP; Roem D; Nieuwenhuys EJ; Kamp AM; Swaak TJ; Hack CE Arthritis Rheum; 1992 Aug; 35(8):884-93. PubMed ID: 1379429 [TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377 [TBL] [Abstract][Full Text] [Related]
8. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic and inflammatory processes in pleural effusions. Philip-Joët F; Alessi MC; Philip-Joët C; Aillaud M; Barriere JR; Arnaud A; Juhan-Vague I Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803 [TBL] [Abstract][Full Text] [Related]
10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [TBL] [Abstract][Full Text] [Related]
11. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. Houard X; Rouzet F; Touat Z; Philippe M; Dominguez M; Fontaine V; Sarda-Mantel L; Meulemans A; Le Guludec D; Meilhac O; Michel JB J Pathol; 2007 May; 212(1):20-8. PubMed ID: 17352452 [TBL] [Abstract][Full Text] [Related]
12. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. Kinnby B; Matsson L; Astedt B J Periodontal Res; 1996 May; 31(4):271-7. PubMed ID: 8814598 [TBL] [Abstract][Full Text] [Related]
13. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. van Hinsbergh VW; Bauer KA; Kooistra T; Kluft C; Dooijewaard G; Sherman ML; Nieuwenhuizen W Blood; 1990 Dec; 76(11):2284-9. PubMed ID: 1701665 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of t-PA, u-PA, PAI-1 and PAI-2 estimation in human bile by ELISA kits. Kondera-Anasz Z; Michalski A; Gil D; Gil B; Starzewski J; Gonciarz Z Med Sci Monit; 2000; 6(3):616-7. PubMed ID: 11208381 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of plasminogen activators in human gingival crevicular fluid. Brown JM; Watanabe K; Cohen RL; Chambers DA Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2. Perides G; Noring R; Klempner MS Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243 [TBL] [Abstract][Full Text] [Related]
17. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study. De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228 [TBL] [Abstract][Full Text] [Related]
19. The Role of Fibrinolytic System in Health and Disease. Kwaan HC Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651 [TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]